Related references
Note: Only part of the references are listed.Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease A Randomized Controlled Trial
Hiroaki Hayashi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Benefits and harms of aspirin desensitization for aspirin-exacerbated respiratory disease: a systematic review and meta-analysis
Derek K. Chu et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2019)
A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease
Katherine L. Tuttle et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Respiration Modulates Olfactory Memory Consolidation in Humans
Artin Arshamian et al.
JOURNAL OF NEUROSCIENCE (2018)
Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease
Jacqueline J. Eastman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Automated identification of an aspirin-exacerbated respiratory disease cohort
Katherine N. Cahill et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial
Claus Bachert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Aspirin-Exacerbated Respiratory Disease - New Prime Suspects
Tanya M. Laidlaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature
Jessica P. Rajan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Omalizumab in the treatment of aspirin-exacerbated respiratory disease
Karl-Christian Bergmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)
Tolerance of daily low-dose aspirin does not preclude aspirin-exacerbated respiratory disease
Kathleen Lee-Sarwar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)
Survey-Defined Patient Experiences With Aspirin-Exacerbated Respiratory Disease
Von Ta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)
Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study
Monika Swierczynska-Krepa et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease
Rachel U. Lee et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease
Andrew P. Hope et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease
Marcus Shaker et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease
Andrew White et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2006)
Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics
DD Stevenson et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2000)
Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry
J Casadevall et al.
THORAX (2000)
Share Paper
